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Abstract
Blood banking has a broad public health impact influencing millions of lives daily. It could potentially benefit from
emerging biopreservation technologies. However, although vitrification has shown advantages over traditional
cryopreservation techniques, it has not been incorporated into transfusion medicine mainly due to throughput challenges.
Here, we present a scalable method that can vitrify red blood cells in microdroplets. This approach enables the vitrification
of large volumes of blood in a short amount of time, and makes it a viable and scalable biotechnology tool for blood
cryopreservation.
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Introduction
Blood shortages pose a major global health challenge that
frequently occur during natural disasters, military conflicts, and in
clinical settings due to fluctuations in supply and demand [1].
Long-term cryopreservation of blood products provides a
supplementary inventory to help meet the demand during such
shortages by freezing excess blood. Although the use of additive
preservatives has extended the liquid storage of blood products to
several weeks (i.e., 42 days for red blood cells (RBCs) [2,3,4]), the
limited shelf life makes it difficult to manage blood inventories
resulting in a large waste [5]. For instance, in 2006, 1.2 million
units of blood were discarded in the US alone [6,7]. New
technologies can potentially revolutionize how blood is handled in
war and global disaster zones, prevent waste, and reduce
vulnerability to shortages.
Over the last century, significant progress has been made in
understanding the basic factors leading to cryoinjury in RBCs and
in development of effective techniques to prevent it [5,8]. Two
major clinical RBC cryopreservation approaches have been
established: the high glycerol/slow freezing [9,10] and the low
glycerol/rapid freezing [11,12,13] techniques. The high glycerol/
slow freezing technique uses 40% (w/v) glycerol with a cooling
rate of ,1uC/min and storage at 280uC. The low glycerol/rapid
freezing approach uses 15–20% glycerol with rapid cooling rates
(60–120uC/min) by immersing samples in freezing containers into
liquid nitrogen (2196uC) or nitrogen vapor (2165uC) [1].
However, although both RBC cryopreservation methods are
considered effective, cryoinjury to RBCs still occurs during the
cooling and warming processes as a result of cell shrinkage [14,15],
toxicity due to the increasing concentrations of solutes [16,17,18]
during slow freezing, and intracellular ice formation (IIF) during
rapid freezing [19]. In contrast, vitrification as a cryopreservation
method has provided a means to significantly reduce the damage to
various cells and tissues [20,21], since ice crystal formation and the
corresponding intra and extracellular solute accumulation are
prevented. Despite the potential advantages of vitrification, its
broad applicationto RBCbiopreservationhasn’t yetbeen achieved.
Challenges include difficulty to achieve extreme cooling and
thawing rates, toxicity of high cryoprotectant agent (CPA)
concentrations needed to vitrify suspensions at a realizable
temperature, devitrification upon rewarming, and inability to
accommodate freezing of large volumes of blood using microliter
cryo vials. Here, we introduce a high throughput ultra-rapid
vitrification method using cell encapsulating droplets, which could
potentially overcome some of the limitations by lowering the
required CPA concentrations and achieving ultra-rapid cooling
rates via vitrifying RBCs encapsulated in small droplet volumes.
Furthermore, RBCs can be stored in liquid nitrogen directly on the
collection film. This is the first time that a scalable vitrification
method has been introduced to blood cryopreservation. Such
technologies have other broad applications in multiple fields,
including film boiling [22], spray cooling during the heat treatment
of metallic alloys, turbine engines, and nuclear reactors [23].
Results and Discussion
It has been shown that the degree of crystallization during ultra-
rapid cooling increases with an increase in droplet radius,
especially when the dimensionless radii (r*) are above 0.1
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generate RBC encapsulating microdroplets (,100 mm) which can
then be vitrified at high throughput. We investigated three major
parameters affecting the droplet size, including the droplet
collection distance (from ejector tip to droplet collection film),
the flow rate of nitrogen gas and the flow rate of CPA loaded
RBCs. Droplets generated at different nitrogen flow rates (3.2–
4.8 l/min), ejection collecting distances (60–90 mm) were depos-
ited on collection films (Fig. 1a) and the droplet size distributions
were analyzed (Fig. 1b). A decrease in droplet size was observed
when either the nitrogen gas flow rate or ejection collecting
distance was increased (Fig. 1b). However, an increase in flow
rate of CPA loaded RBC solution did not result in a significant
change in droplet size due to the dominant effect of nitrogen gas
flow rate (Fig. 1b, SI Fig. S1b, c, and S2) within the range from
3.2 to 4.8 l/min over the droplet size. By controlling the nitrogen
gas flow rate, droplet diameters were maintained below 100 mmt o
ensure effective vitrification at a low CPA concentration (2.5 M
glycerol, equivalent to a concentration of 23%, SI Table S1)
where we operated our system minimizing possible toxic and
osmotic effects [9,10].
To assess overall hemolysis, we evaluated the percent hemolysis
from each procedure step including CPA loading, ejection, RBC
droplet collection on films, and freezing/thawing at five different
experimental conditions (Fig. 2a). The percent hemolysis of each
step was calculated using SI Eqn. S1. with the absorbance values
determined using Cripps and Harboe methods as shown in SI
Table S2 and Fig. S3. We observed that percent hemolysis due
to freezing/thawing and shear stress during ejection ranged
from 2 to 8% and 5 to 17% across all experimental conditions,
respectively (Fig. 2a). The CPA loading steps led to a smaller
percent hemolysis (2% out of 20% total, SI Table S2) compared
to the ejection and vitrification/thawing steps. We also observed
that, the percent hemolysis by the collection film was negative due
to the possible adhesion of free hemoglobin to the film.
The results showed that an increase in droplet collecting
distance from 60 mm to 90 mm did not change percent hemolysis
either during ejection or freezing/thawing processes at constant
gas flow rates of 3.2 l/min and 4.8 l/min, (Fig. 2a and 2b).
However, keeping the ejection distance constant, when nitrogen
gas flow rate was increased from 3.2 l/min to 4.8 l/min, a
statistically significant increase in percent hemolysis was observed
at ejection distances of 60 mm (increase from 6.9% to 16.16%)
and 90 mm (increase from 8.8% to 14.7%) (SI Table S3 and for
statistical analysis: SI Table S6). These observations
indicated that the ejector gas flow rate affects RBC hemolysis
(Kruskal-Wallis non-parametric analysis of variance, p,0.05) and
damage to cells during droplet generation and encapsulation can
be minimized by changing the gas flow rate. For the vitrification
and thawing steps, an increase in nitrogen flow rate did not have a
significant effect on RBC hemolysis (Fig. 2a and 2b) since the
average droplet diameter was below 100 mm at each flow rate
(Fig. 1b). The combined effects of ejection, freezing, and thawing
at the lowest nitrogen flow rate (3.2 l/min) resulted in the lowest
percent hemolysis (11%) with minimal dependence on ejection
distance.
To demonstrate the scalability of the system, we performed
droplet-based RBC vitrification experiments using arrays of 4 and
25 independent ejectors activated simultaneously (SI Fig. S1c).
The vitrification was performed at an ejection distance of 60 mm,
CPA loaded RBC flow rate of 0.2 ml/min for each ejector and
nitrogen gas flow rate of 3.2 l/min. With this 25-ejector setup, in
5 minutes, the system vitrified 25 ml of RBCs loaded with 2.5 M
glycerol (1:1, v/v). As shown in Fig. 2c and d, the percent
hemolysis using the 4 and 25 ejector systems were 17.5863.56%
and 18.0862.59%, respectively. Compared to the values obtained
using a single ejector (12.0764.92% under the same operation
conditions, as shown in SI Table S3), the use of a multi-ejector
system resulted in only a moderate increase to percent hemolysis.
The Kruskal-Wallis (non-parametric) analysis of variance on the
Figure 1. A schematic drawing of the droplet generating system for the blood cryo-preservation process. (a) Schematic description for
blood droplet ejection on collection film and images of droplets. Scale bar is 500 mm. (b) Size distribution of ejected droplets. Average droplet size
and standard deviation are shown as a function of droplet collecting distance, sheath gas flow rate, and blood flow rate. Error bars are standard
deviations.
doi:10.1371/journal.pone.0017530.g001
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have a significant effect (p.0.05) on the percent hemolysis.
Furthermore, pair-wise comparisons with nonparametric Mann-
Whitney U test on hemolysis values for single to 4, 4 to 25 and
single to 25 ejectors also pointed that the effect of number of
ejectors is insignificant with p scores of 0.08, 1.00, and 0.08,
respectively (SI Table S4 and S5). These results indicated the
scalability of the system to process blood at high throughput.
Further, for the system to become a clinically useable method, the
sterility and avoidance from microbiological contamination are
very important in blood transfusion. As a first step taken towards
this direction, the ejector system is operated in a sterile hood
during ejection, droplet collection and thawing steps.
In summary, we have introduced a scalable vitrification method
for the cryopreservation of RBCs by generating microdroplets that
are vitrified and thawed at low CPA levels. We envision that the
RBC cryopreservation approach presented here has potential to
improve the efficiency with which global blood inventories are
managed leading to significant economic and social downstream
impact.
Materials and Methods
The RBC cryopreservation process consists of four main steps:
blood preparation, CPA loading (SI Fig. S1a), ejection, and
freezing/thawing/collection (SI Fig. S1b). The droplets were
generated from the co-flow stream of the CPA-loaded RBC
solution and nitrogen gas flow through an ejector (SI Fig. S1c).
All experiments were performed in a sterile hood to prevent
microbacterial contamination that could have adverse affects on
the RBCs. All the abbreviations are listed in SI Table S7.
Blood Preparation
All buffy coat samples were received from the Massachusetts
General Hospital transfusion center. The buffy coat was easier to
obtain compared to whole blood, and prepared specifically for
research use. To isolate RBCs, 25 ml of buffy coat sample was first
mixed with 3.5 ml of Citrate Phosphate Dextrose Adenine
(CPDA-1) anticoagulant for 2 min at 20uC, and then centrifuged
at 2000 rpm for 10 min at 20uC (Allegra 6 Centrifuge, Beckman
Coulter, USA). After removing the supernatant, approximately
Figure 2. Percent hemolysis values for ejection and freezing at five different conditions (a) Cripps method and (b) Harboe method.
P-values were tested at two different distances (60 and 90 mm) and gas flow rates (3.2 and 4.8 l/min), SI Table S6. Percent hemolysis values of
parallel ejection systems were shown for (c) 4 parallel ejectors and (d) 25 parallel ejectors system. Both 4 and 25 ejector systems were operated at
3.2 l/min and 6 mm.
doi:10.1371/journal.pone.0017530.g002
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CPDA-1, 327 mg citric acid, 2.635 g sodium citrate, 222 mg
monobasic sodium phosphate, 3.175 g dextrose, 27 mg adenine
were used.
CPA Loading
The CPA solutions at different concentrations (1M, 2M, 2.5M
and 4M) were prepared, and the compositions were listed in SI
Table S1. 5 ml of collected RBC pellet was first mixed with 2M
glycerol at a ratio of 1:1 (v/v) (Sigma, USA) to achieve a final
glycerol concentration of 1M. The mixture was then centrifuged at
2000 rpm for 10 minutes and the isolated RBCs containing 1M
glycerol were collected, and then further mixed with 4M glycerol
at a ratio of 1:1 (v/v) to obtain a final glycerol concentration of
2.5M.
Cell Encapsulating Droplet Generation System
The droplet generation system is shown in Fig. 1a and SI Fig.
S1c. An ejector was built using a 200 ml pipette tip attached to a
27 gage stainless needle tip (BD Biosciences, San Jose, CA). The
needle tip was placed into the center of the pipette tip to build a
co-flow nozzle. The two components were assembled by inserting
the needle tip across pipette tip wall at a point 2 cm away from the
pipette tip end. The needle tip was pushed further inside the
pipette tip until it stuck out 2 mm from the edge. A nitrogen gas
tank was connected to the pipette tip with TygonH tubing
(ID=3.2 mm) (Saint-Gobain Performance Plastics, Worcester,
MA) through which the gas could flow to the pipette tip (Supp.
Fig. 1c). A CPA loaded RBC sample was loaded into a syringe
attached to a 30 gage needle (Small Parts Inc., Miramar, FL). A
15 cm polyethylene tubing (Becton Dickinson Primary Care
Diagnostics, Sparks, MD) through which the sample could flow
was then used to connect the blood loaded syringe and ejector
through the needle tip. The RBC sample loaded with CPAs was
then loaded into a syringe pump (World Precision Instrument,
Sarasota, FL) Nitrogen gas was flowed through the Tygon tubing
to the pipette tip simultaneously while the CPA loaded RBC
solution was pumped from the syringe pump and flowed through
the polyethylene tubing to the needle tip, resulting in a force that
created droplets from the needle tip of the ejector (Fig. 1a). The
ejector was cleaned with ethanol and autoclaved before use.
Vitrification of RBCs
The RBC sample loaded with CPAs was delivered to the ejector
from the syringe pump at a flow rate of 0.2 ml/min. The nitrogen
gas was supplied from the nitrogen gas tank and delivered to the
ejector through TygonH tubing at a rate of 4 l/min. For the
vitrification of RBCs, the droplets were first ejected onto a
polyethylene (PE) collection film (Avery, Brea, CA) of 8.5 mm
diameter. Then, the film with the RBC droplets attached was
rapidly immersed into liquid nitrogen using pre-cooled tweezers.
Thawing and Collection of RBCs
For the thawing, the film with the CPA loaded RBC droplets
attached was removed from the liquid nitrogen using tweezers and
immediately transferred in a petri dish filled with a thawing
solution consisting of 10 ml of 2.5M glycerol pre-warmed to 25uC
(Supp. Fig. S1c). The film was surrounded by liquid nitrogen
vapor during the transfer to prevent any devitrification prior to
immersion in the thawing solution. The film with the CPA loaded
RBC droplets was immersed completely in the thawing solution
and the droplets were washed completely off the film and into the
thawing solution. Once the vitrified droplets were completely
thawed and the RBCs were washed into the thawing solution, the
mixture containing RBCs and 2.5M glycerol was then collected
and centrifuged at 2000 RPM for 10 min. The supernatant was
then removed and RBCs in 2.5M glycerol solution were collected.
Droplet size measurement
Since the degree of crystallization of the droplet increases with
droplet size, we measured the droplet size distribution at 5
different experimental conditions. Three major variables were
investigated for their effects on droplet size distribution, including
(i) droplet collection distance between ejector tip and droplet
collection film, (ii) flow rate of nitrogen gas, and (iii) the flow rate of
CPA loaded RBCs. At each operation condition, droplets were
ejected onto the surface of a 150 mm polystyrene petri-dish, and
then images were taken using a microscope (TE 2000; Nikon,
Japan). The images were taken at 106 magnification, and the
number of droplets and their diameters were measured using
Image J (NIH, Bethesda). To create an accurate read-out of the
droplet diameter, the images were first adjusted to desired
threshold level (0,255 for 8bit gray scale image). Droplets that
did not initially appear as closed circles on the image were
modified using black/white threshold imaging process and the dot
tools of image J. Then the data acquired was transferred to Excel
where measurements were converted from pixels to micrometers
to obtain droplet size (one pixel=1.28 mm). Finally, the distribu-
tion of droplet size was plotted using Sigmaplot (Systat Software
Inc., Chicago, IL). The results were shown in SI Fig. S2a and
S2b.
Percent Hemolysis Analysis
To better understand how each procedure impacts the final
RBC hemolysis after vitrification, we analyzed for the percent
hemolysis for each step (i.e., CPA loading, droplet ejection,
collecting droplets on film, and freezing/thawing). We calculated
the percent hemolysis by comparing the free hemoglobin in
solution after each process is performed to those of controls. The
controls were the free hemoglobin present in a sample which is
prepared before a given step is performed and in a sample which is
prepared with DI water for 100% hemolysis value. The first
control sample shows how much hemoglobin is already present
before a step is performed and the second control shows how
much hemoglobin is present when 100% hemolysis occurs.
Percent hemolysis can be expressed by the following equation
[1–5]:
Hemolysis (%)~
ABSprocess-ABS0
ABS100-ABS0
|100 ð1Þ
Where ABS0 and ABSprocess are the absorbance of free hemo-
globin in RBC samples before and after each step of the RBC
encapsulating droplet cryopreservation process is performed,
respectively. ABS100 is the absorbance of free hemoglobin in
RBC samples after total cell lysis in DI water. The numerator
represents the amount of hemoglobin released during a given
experimental step while the denominator represents the total
amount of hemoglobin present in the RBCs before this step was
performed. The fraction of hemoglobin that was intact in the cells
is given by, ABS100{ABS0, before a given step is performed. The
hemoglobin released from the cells while the step was being
performed is given by, ABSprocess{ABS0. Dividing the numer-
ator by the denominator gives the percentage of hemolysis.
Absorbance was measured using an UV-VIS spectrophotometer
(UV-2450, SHIMADZU, Japan) as shown in SI Fig. S3.
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[25], which are two standard methods to calculate hemolysis based
on hemoglobin absorbance at different wavelengths. Results of
each process step were presented with these spectrophotometer
values, SI Table S2.
Hemolysis due to loading of CPA1 (addition of 2M CPA to
RBC pellet for a final 1M CPA concentration)
To prevent ice crystals from forming in the RBCs during
freezing/thawing, CPAs must be loaded to the cells. Before the
CPA1 loading step was performed, two control samples were
prepared to obtain absorbance measurements (ABS0 CPA1 and
ABS100 CPA1). A 20 ml sample of isolated RBCs was added to
10 ml of Dulbecco’s Phosphate Buffered Saline (DPBS) (GIBCO,
Grand Island, NY) to dilute the RBCs to a concentration within
the range of the spectrophotometer reading where free hemoglo-
bin is linearly correlated to the absorbance, for ABS0 CPA1
measurement. Since minimal hemolysis occurs during the addition
of DPBS, the absorbance value obtained accurately reflects the
free hemoglobin concentration before 2M glycerol was loaded. To
obtain a RBC sample for ABS100 CPA1 measurement, a 20 ml
sample of isolated RBCs was added to 10 ml of deionized (DI)
water to obtain a total cell lysis. To perform the first CPA loading
step, 1 ml of isolated RBCs was mixed with 2M glycerol with a
ratio of 1:1 (v/v) (Sigma, USA) to obtain a RBC sample with a
final glycerol concentration of 1M. Then 40 ml of this CPA loaded
sample was mixed with 9.98 ml of 1M glycerol to match the same
mixing ratios as the control samples. These three samples were
then centrifuged at 2000 rpm for 10 min and the absorbance of
the supernatants was measured using the UV-VIS spectropho-
tometer (UV-2450, Shimadzu, Japan).
Hemolysis due to loading of CPA2 (addition of 4M CPA to
RBCs in 1M CPA solution for a final 2.5M CPA
concentration)
Two 20 mL samples of isolated RBCs loaded with 1M glycerol
were taken into two tubes. One sample was diluted with 10 ml of
1M glycerol, and the other was diluted with 10 ml of DI water to
obtain control samples for ). For pairwise comparisons, one-tailed
p-value was used to evaluate the effect of ejection distance and gas
flow on percent hemolysis; whereas two-tailed p-value was used to
evaluate the effect of number of ejectors on percent hemolysis.
Supporting Information
Figure S1 Overall schematic of the blood cryopreserva-
tion setup and process steps. (a) CPA loading process for
whole blood, (b) Vitrification process (c) Picture of multi-ejector
setup, ejector length (Lext) and needle tip (Dneedle) was 3.0 mm
outer diameter and 210 mm inner diameter (27 gauge needle).
Scale bar is 1 mm.
(TIF)
Figure S2 Droplet size measurements. (a) Images of
ejected droplets on collection film. Outline tracking, measuring
size, and counting of droplets using Image J software. Droplets
were collected on paper with three different distances and sheath
flow rates at a fixed blood flow rate, 200 ml/min. Droplet
diameters were calculated using the area of each closed outline.
(b) Droplet size distribution is shown as a function of droplet
collecting distance, gas flow rate, and blood flow rate.
(TIF)
Figure S3 Absorbance values and percent hemolysis for
different steps during cryopreservation process. Percent
hemolysis was measured for each process step following Eqn. S1
as described in the Percent Hemolysis Analysis section in the
manuscript. Each dotted box represents how each process affects
hemolysis, i.e. (a) CPA1 loading effect (ABSCPA1), (b) CPA2
loading effect (ABSCPA2), (c) ejection effect (ABSejection), and (d)
freezing and thawing (ABSfreeze) effect.
(DOCX)
Table S1 Composition of the cryoprotective solutions
used (g/40 ml).
(DOC)
Table S2 Spectrometer absorbance values for the two
controls and actual sample from each step in the
cryopreservation process from experimental conditions
of 75 mm droplet collecting distance and 4.0 l/min of
sheath gas flow rate).
(DOC)
Table S3 Percent hemolysis values of ejection, collec-
tion film, and freezing for five different experimental
conditions are given. Total hemolysis is the sum of hemolysis
due to the ejection and freezing steps.
(DOC)
Table S4 Cryopreservation process for multiple ejec-
tors (4 ejectors).
(DOC)
Table S5 Cryopreservation process for multiple ejec-
tors (25 ejectors).
(DOC)
Table S6 Nonparametric Mann-Whitney U test results
(p-values) of pairwise comparisons for ejection at two
different distances (60 and 90 mm) and gas flow rates
(3.2 and 4.8 l/min) for Cripps method(*) and Harboe
method(**). Freezing was not affected from the ejection
conditions as per nonparametric Kruskal-Wallis one way analysis
of variance, therefore pairwise comparisons were not performed.
(DOC)
Table S7 Appendix for symbols.
(DOCX)
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